87 related articles for article (PubMed ID: 25168880)
21. Matrix metalloproteinases are key targets of acupuncture in the treatment of ulcerative colitis.
Zhang RB; Dong LC; Huang Q; Shen Y; Li HY; Yu SG; Wu QF
Exp Biol Med (Maywood); 2023 Jul; 248(14):1229-1241. PubMed ID: 37438919
[TBL] [Abstract][Full Text] [Related]
22. Targeting matrix metalloproteases in diabetic wound healing.
Chen J; Qin S; Liu S; Zhong K; Jing Y; Wu X; Peng F; Li D; Peng C
Front Immunol; 2023; 14():1089001. PubMed ID: 36875064
[TBL] [Abstract][Full Text] [Related]
23. The association of vitamin D status with oxidative stress biomarkers and matrix metalloproteinases in patients with knee osteoarthritis.
Amirkhizi F; Ghoreishy SM; Baker E; Hamedi-Shahraki S; Asghari S
Front Nutr; 2023; 10():1101516. PubMed ID: 36845046
[TBL] [Abstract][Full Text] [Related]
24. Signaling pathways in cutaneous wound healing.
Krizanova O; Penesova A; Sokol J; Hokynkova A; Samadian A; Babula P
Front Physiol; 2022; 13():1030851. PubMed ID: 36505088
[TBL] [Abstract][Full Text] [Related]
25. Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets.
Fu K; Zheng X; Chen Y; Wu L; Yang Z; Chen X; Song W
Front Pharmacol; 2022; 13():1050630. PubMed ID: 36339630
[TBL] [Abstract][Full Text] [Related]
26. Proteomics changes after negative pressure wound therapy in diabetic foot ulcers.
Jia Z; Liu L; Zhang S; Zhao X; Luo L; Tang Y; Shen B; Chen M
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34608502
[TBL] [Abstract][Full Text] [Related]
27. Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing Elective Percutaneous Coronary Intervention.
Foroughinia F; Mirjalili M
Iran J Pharm Res; 2020; 19(4):135-142. PubMed ID: 33841529
[TBL] [Abstract][Full Text] [Related]
28. [Mechanisms of adrenergic β-antagonist for wounds and its application prospect in diabetic foot ulcers].
Sun S; Ma J; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Dec; 34(12):1630-1634. PubMed ID: 33319548
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D Deficiency and the Risk of Cerebrovascular Disease.
Kim HA; Perrelli A; Ragni A; Retta F; De Silva TM; Sobey CG; Retta SF
Antioxidants (Basel); 2020 Apr; 9(4):. PubMed ID: 32316584
[TBL] [Abstract][Full Text] [Related]
30. Effects of 1,25-Dihydroxy vitamin D
Avcioglu G; Özbek Ipteç B; Akcan G; Görgün B; Fidan K; Carhan A; Yilmaz G; Kozaci LD
Mol Cell Biochem; 2020 Jan; 464(1-2):131-142. PubMed ID: 31734843
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D in Cardiovascular Disease.
Nitsa A; Toutouza M; Machairas N; Mariolis A; Philippou A; Koutsilieris M
In Vivo; 2018; 32(5):977-981. PubMed ID: 30150419
[TBL] [Abstract][Full Text] [Related]
32. Alginate membranes loaded with hyaluronic acid and silver nanoparticles to foster tissue healing and to control bacterial contamination of non-healing wounds.
Tarusha L; Paoletti S; Travan A; Marsich E
J Mater Sci Mater Med; 2018 Feb; 29(3):22. PubMed ID: 29396683
[TBL] [Abstract][Full Text] [Related]
33. High Vitamin D Levels May Downregulate Inflammation in Patients with Behçet's Disease.
Adeeb F; Khan MU; Li X; Stack AG; Devlin J; Fraser AD
Int J Inflam; 2017; 2017():8608716. PubMed ID: 28660088
[TBL] [Abstract][Full Text] [Related]
34. LL-37 but Not 25-Hydroxy-Vitamin D Serum Level Correlates with Healing of Venous Leg Ulcers.
Krejner A; Litwiniuk M; Grzela T
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):455-461. PubMed ID: 27663530
[TBL] [Abstract][Full Text] [Related]
35. The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation.
Ayuk SM; Abrahamse H; Houreld NN
J Diabetes Res; 2016; 2016():2897656. PubMed ID: 27314046
[TBL] [Abstract][Full Text] [Related]
36. Alterations of Dermal Connective Tissue Collagen in Diabetes: Molecular Basis of Aged-Appearing Skin.
Argyropoulos AJ; Robichaud P; Balimunkwe RM; Fisher GJ; Hammerberg C; Yan Y; Quan T
PLoS One; 2016; 11(4):e0153806. PubMed ID: 27104752
[TBL] [Abstract][Full Text] [Related]
37. Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers.
López-López N; González-Curiel I; Treviño-Santa Cruz MB; Rivas-Santiago B; Trujillo-Paez V; Enciso-Moreno JA; Serrano CJ
Arch Dermatol Res; 2014 Nov; 306(9):809-21. PubMed ID: 25168880
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
40. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
